Literature DB >> 15173050

The clinician as investigator: participating in clinical trials in the practice setting.

Ellis W Lader, Christopher P Cannon, E Magnus Ohman, L Kristin Newby, Daniel P Sulmasy, Robyn J Barst, Joan M Fair, Marcus Flather, Jane E Freedman, Robert L Frye, Mary M Hand, Robert L Jesse, Frans Van de Werf, Fernando Costa.   

Abstract

The rapid development of new drugs, therapies, and devices has created a dramatic increase in the number of trials needed to properly evaluate them. The majority of patients treated today, many of whom could be eligible for participation in these studies, are seen in community hospitals and medical practices that are not affiliated with an academic medical center. Thus, there is a demonstrable need for physicians in private practice to enlist as investigators in these trials. This article is intended to encourage those physicians by describing the need and providing the rationale for their participation. It covers basic requirements for participating in clinical trials and outlines ethical, regulatory, financial, and other logistical issues of importance for the potential investigator and provides an algorithm for selecting a study for participation. Finally, the appendices review basic elements of study design and statistical principles, which may be of interest to a potential investigator.

Entities:  

Mesh:

Year:  2004        PMID: 15173050     DOI: 10.1161/01.CIR.0000128702.16441.75

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  10 in total

Review 1.  [Systematic errors in clinical studies : A comprehensive survey].

Authors:  W A Golder
Journal:  Ophthalmologe       Date:  2017-03       Impact factor: 1.059

Review 2.  [Systematic errors in clinical studies : A comprehensive survey].

Authors:  W A Golder
Journal:  Z Rheumatol       Date:  2017-02       Impact factor: 1.372

Review 3.  Rules of engagement: Promoting academic-industry partnership in the era of digital pathology and artificial intelligence.

Authors:  Liron Pantanowitz; Marilyn M Bui; Chhavi Chauhan; Ehab ElGabry; Lewis Hassell; Zaibo Li; Anil V Parwani; Mohamed E Salama; Manu M Sebastian; David Tulman; Suryanarayana Vepa; Michael J Becich
Journal:  Acad Pathol       Date:  2022-05-30

4.  Practicing research ethics: private-sector physicians & pharmaceutical clinical trials.

Authors:  Jill A Fisher
Journal:  Soc Sci Med       Date:  2008-03-18       Impact factor: 4.634

5.  Sharing of Investigational Drug Among Participants in the Voice Trial.

Authors:  Jeeva Moodley; Sarita Naidoo; Jayajothi Moodley; Gita Ramjee
Journal:  AIDS Behav       Date:  2016-11

6.  Institutional mistrust in the organization of pharmaceutical clinical trials.

Authors:  Jill A Fisher
Journal:  Med Health Care Philos       Date:  2008-07-17

7.  Community hospital oversight of clinical investigators' financial relationships.

Authors:  Mark A Hall; Kevin P Weinfurt; Janice S Lawlor; Joëlle Y Friedman; Kevin A Schulman; Jeremy Sugarman
Journal:  IRB       Date:  2009 Jan-Feb

8.  Physician participation in clinical research and trials: issues and approaches.

Authors:  Sayeeda Rahman; Md Anwarul Azim Majumder; Sami F Shaban; Nuzhat Rahman; Moslehuddin Ahmed; Khalid Bin Abdulrahman; Urban Ja D'Souza
Journal:  Adv Med Educ Pract       Date:  2011-03-07

9.  United States private-sector physicians and pharmaceutical contract research: a qualitative study.

Authors:  Jill A Fisher; Corey A Kalbaugh
Journal:  PLoS Med       Date:  2012-07-24       Impact factor: 11.069

10.  How to improve the implementation of academic clinical pediatric trials involving drug therapy? A qualitative study of multiple stakeholders.

Authors:  Delphine Girard; Olivier Bourdon; Hendy Abdoul; Sonia Prot-Labarthe; Françoise Brion; Annick Tibi; Corinne Alberti
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.